Aberdeen Group
TECH icon

Aberdeen Group’s Bio-Techne TECH Stock Holding History

Aberdeen Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$477K Sell
6,746
-1,464
-18% -$79.1K ﹤0.01% 888
2026
Q1 		$429K Sell
8,210
-7,403
-47% -$444K ﹤0.01% 893
2025
Q4 		$918K Buy
15,613
+6,637
+74% +$403K ﹤0.01% 840
2025
Q3 		$499K Sell
8,976
-88,152
-91% -$4.72M ﹤0.01% 892
2025
Q2 		$5M Buy
97,128
+2,736
+3% +$137K 0.01% 706
2025
Q1 		$5.49M Buy
94,392
+48,730
+107% +$3.3M 0.01% 671
2024
Q4 		$3.29M Sell
45,662
-2,380
-5% -$175K 0.01% 709
2024
Q3 		$3.8M Buy
48,042
+2,492
+5% +$187K 0.01% 694
2024
Q2 		$3.26M Sell
45,550
-19,890
-30% -$1.46M 0.01% 695
2024
Q1 		$4.61M Buy
65,440
+127
+0.2% +$9.09K 0.01% 682
2023
Q4 		$5.04M Buy
65,313
+26,901
+70% +$1.77M 0.01% 667
2023
Q3 		$2.61M Sell
38,412
-1,411
-4% -$111K 0.01% 658
2023
Q2 		$3.25M Sell
39,823
-4,456
-10% -$358K 0.01% 646
2023
Q1 		$3.29M Sell
44,279
-127
-0.3% -$9.79K 0.01% 651
2022
Q4 		$3.68M Sell
44,406
-1,362
-3% -$108K 0.01% 602
2022
Q3 		$3.25M Sell
45,768
-8,928
-16% -$771K 0.01% 620
2022
Q2 		$4.73M Buy
54,696
+3,616
+7% +$339K 0.01% 557
2022
Q1 		$5.61M Sell
51,080
-888
-2% -$91.6K 0.01% 553
2021
Q4 		$6.72M Sell
51,968
-2,120
-4% -$260K 0.01% 582
2021
Q3 		$6.66M Buy
54,088
+50,652
+1,474% +$6.16M 0.02% 596
2021
Q2 		$387K Buy
+3,436
New +$362K ﹤0.01% 957

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Aberdeen Group's TECH Position: Q2 2026 in Review

Aberdeen Group reduced its Bio-Techne (TECH) stake by 18% in Q2 2026, selling an estimated $79.1K and leaving 6,746 shares worth $477K. The position accounts for ﹤0.01% of the portfolio, ranked #888.

Aberdeen Group first reported a position in TECH in Q2 2021 and has held it in 21 quarters since. The position peaked at $6.72M in Q4 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Aberdeen Group held 6,746 shares of Bio-Techne worth $477K as of Q2 2026.
  • Aberdeen Group sold 1,464 Bio-Techne shares in Q2 2026, an estimated $79.1K.
  • Bio-Techne made up ﹤0.01% of Aberdeen Group's portfolio in Q2 2026, its #888 holding.
  • Aberdeen Group first reported a position in Bio-Techne in Q2 2021 and has held it in 21 quarters since.
  • Aberdeen Group's Bio-Techne position peaked at $6.72M in Q4 2021.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.